Characteristics of Lymphedema in Patients Treated with Mammalian Target of Rapamycin Inhibitors-Reference-Cited by-同舟云学术

Characteristics of Lymphedema in Patients Treated with Mammalian Target of Rapamycin Inhibitors

Published:2021-08-01 Issue:4 Volume:19 Page:365-371
ISSN:1539-6851
Container-title:Lymphatic Research and Biology
language:en
Short-container-title:Lymphatic Research and Biology

Author:

Kim JaYoung¹,Jeon Jae Yong¹,Ko Young Min²,Kang Min Soo¹,Park Su-Kil³,Roh Kangsan⁴

Affiliation:

1. Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

2. Division of Kidney and Pancreas Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

3. Division of Nephrology, Department of Internal Medicine, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea.

4. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Publisher

Mary Ann Liebert Inc

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/lrb.2020.0069

Reference37 articles.

1. Lymphedema of the Transplanted Kidney and Abdominal Wall with Ipsilateral Pleural Effusion Following Kidney Biopsy in a Patient Treated with Sirolimus: A Case Report and Review of the Literature

2. Current treatment strategies for inhibiting mTOR in cancer

3. m-TOR inhibitors and risk of Pneumocystis pneumonia after solid organ transplantation: a systematic review and meta-analysis

4. Oedema, solid organ transplantation and mammalian target of rapamycin inhibitor/proliferation signal inhibitors (mTOR-I/PSIs)

5. Sirolimus and everolimus in kidney transplantation

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does lympho-venous anastomosis effect for mTOR inhibitor-associated lymphedema patients?;Archives of Plastic Surgery;2023-10-30

2. Elephantiasis nostras verrucosa induced by everolimus;Italian Journal of Dermatology and Venereology;2023-10

3. Electron transport chain and mTOR inhibition synergistically decrease CD40 signaling and counteract venetoclax resistance in chronic lymphocytic leukemia;Haematologica;2023-07-13

4. Riding up the escaLEC-TOR for valvular health;Journal of Cell Biology;2023-05-25

5. How we approach lymphedema in the pediatric population;Pediatric Blood & Cancer;2022-08